DNA adducts induced by platinum drug chemotherapeutic agents in human tissues
Poirier, M.C.; Shamkhani, H.; Reed, E.; Tarone, R.E.; Gupta-Burt, S.
Progress in Clinical and Biological Research 374: 197-212
1992
ISSN/ISBN: 0361-7742 PMID: 1620704 Document Number: 390535
Document emailed within 1 workday
Related Documents
Johnson, S.W.; Laub, P.B.; Beesley, J.S.; Ozols, R.F.; Hamilton, T.C. 1997: Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines Cancer Research 57(5): 850-856Mamenta, E.L.; Poma, E.E.; Kaufmann, W.K.; Delmastro, D.A.; Grady, H.L.; Chaney, S.G. 1994: Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines Cancer Research 54(13): 3500-3505
Farmer, P.B.; Bailey, E.; Green, J.A.; Leung, C.S.; Manson, M.M. 1991: Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA Iarc Scientific Publications 105: 71-77
Keller, J.H.; Ensminger, W.D. 1982: Stability of cancer chemotherapeutic agents in a totally implanted drug delivery system American Journal of Hospital Pharmacy 39(8): 1321-1323
Leng, M.; Brabec, V. 1994: DNA adducts of cisplatin, transplatin and platinum-intercalating drugs Iarc Scientific Publications 125: 339-348
Looney, W.B.; Hopkins, H.A. 1989: Modification of radiotherapy by radiosensitizers and cancer chemotherapeutic agents. II. Cancer chemotherapeutic agents Seminars in Oncology 16(3): 176-179
Ishikawa, H.; Kikkawa, F.; Tamakoshi, K.; Matsuzawa, K.; Kawai, M.; Suganuma, N.; Tomoda, Y. 1996: Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy Anticancer Research 16(6b): 3849-3853
Hausheer, F.H.; Kanter, P.; Cao, S.; Haridas, K.; Seetharamulu, P.; Reddy, D.; Petluru, P.; Zhao, M.; Murali, D.; Saxe, J.D.; Yao, S.; Martinez, N.; Zukowski, A.; Rustum, Y.M. 1998: Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents Seminars in Oncology 25(5): 584-599
de la Torre, M.; Hao, X.Y.; Larsson, R.; Nygren, P.; Tsuruo, T.; Mannervik, B.; Bergh, J. 1993: Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases Anticancer Research 13(5a): 1425-1430
Kelland, L.R.; Abel, G.; McKeage, M.J.; Jones, M.; Goddard, P.M.; Valenti, M.; Murrer, B.A.; Harrap, K.R. 1993: Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug Cancer Research 53(11): 2581-2586
Bellet, R.E.; Danna, V.; Mastrangelo, M.J.; Berd, D. 1979: Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents Journal of the National Cancer Institute 63(5): 1185-1188
Ohzato, H.; Satomi, T.; Sakita, I.; Ishida, H.; Hoshi, O.; Kawasaki, T.; Sakaguchi, A. 1988: Two cases of cloacogenic carcinoma of the anal canal: chemotherapeutic effect of cis-dichlorodiammine-platinum Nihon Geka Gakkai Zasshi 89(8): 1291-1295
Wu, Q.-g.; Cao, T.-t.; Cheng, Z.; Wang, J. 2011: Effects of Akt2-siRNA on chemotherapeutic sensitivity and drug resistance in human lung cancer cells Zhonghua Yi Xue Za Zhi 91(30): 2139-2142
Hannemann, J.; Baumann, K. 1988: Inhibition of lactate-dehydrogenase by cisplatin and other platinum-compounds: enzyme leakage of LDH is not a suitable method to measure platinum-compound-induced kidney cell damage in vitro Research Communications in Chemical Pathology and Pharmacology 60(3): 371-379
Broder, L.E.; Weintraub, B.D.; Rosen, S.W. 1978: Influence of chemotherapeutic agents on chorionic gonadotropin-alpha subunit secretion in a human lung cancer cell line (ChaGo): discordance of cytotoxic and secretory effects Journal of the National Cancer Institute 61(2): 349-351
Sawada, M.; Ozaki, M.; Taniguchi, H.; Tateishi, R.; Mori, Y.; Mino, K. 1988: Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Part 1): 637-641
Ross, S.A.; Carr, C.A.; Brïet, J.W.; Lowe, G. 2000: Transfer of 4'-chloro-2,2':6',2"-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. a possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells Anti-Cancer Drug Design 15(6): 431-439
Shen, M.; Feng, Y.; Zhou, X. 1999: Effect of liposome-C-erbB2 antisense oligodeoxynucleotides on the growth and the chemotherapeutic drug sensitivity of human ovarian cancer transplanted in the omentum of nude mice Zhonghua Fu Chan Ke Za Zhi 34(2): 110-112
Parris, C.N.; Walker, M.C.; Masters, J.R.; Arlett, C.F. 1990: Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies Cancer Research 50(23): 7513-7518
Narita, I. 2016: Drug-induced kidney injury due to antibiotic agents Nihon Jinzo Gakkai Shi 58(7): 1069-1072